T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Coupang
CPNG
$29.3B
| $611M | 0.08% |
47,947,638
+5,919,724
| +14% | +$80.7M |
|
252
Casey's General Stores
CASY
$31B
| $609M | 0.08% |
3,290,009
-869,596
| -21% | -$175M |
|
|
EXAS
253
DELISTED
Exact Sciences
EXAS
| $607M | 0.08% |
15,422,384
-3,757,848
| -20% | -$201M |
|
254
Endava
DAVA
$162M
| $605M | 0.08% |
6,855,250
+972,001
| +17% | +$102M |
|
255
Crown Castle
CCI
$31.5B
| $602M | 0.08% |
3,577,218
+752,420
| +27% | +$137M |
|
256
AXIS Capital
AXS
$7.26B
| $602M | 0.08% |
10,546,653
-87,587
| -0.8% | -$4.99M |
|
257
Live Nation Entertainment
LYV
$43.2B
| $600M | 0.08% |
7,261,841
-434,048
| -6% | -$41.8M |
|
258
IDEX
IEX
$17.7B
| $598M | 0.08% |
3,292,370
-218,025
| -6% | -$41.1M |
|
259
WEC Energy
WEC
$35.6B
| $594M | 0.08% |
5,902,916
+1,296,919
| +28% | +$131M |
|
260
TSMC
TSM
$2.23T
| $593M | 0.07% |
7,251,574
-2,557,965
| -26% | -$237M |
|
261
Marriott International
MAR
$92.5B
| $592M | 0.07% |
4,350,364
+1,055,986
| +32% | +$174M |
|
262
MGM Resorts International
MGM
$11.1B
| $591M | 0.07% |
20,424,636
+3,322,373
| +19% | +$119M |
|
263
Franco-Nevada
FNV
$45.5B
| $587M | 0.07% |
4,475,210
+134,982
| +3% | +$20M |
|
264
Canadian Pacific Kansas City
CP
$81.5B
| $583M | 0.07% |
8,348,181
+960,720
| +13% | +$69.6M |
|
265
Lattice Semiconductor
LSCC
$18.4B
| $578M | 0.07% |
11,909,504
+3,013,254
| +34% | +$150M |
|
266
Monolithic Power Systems
MPWR
$70B
| $563M | 0.07% |
1,466,393
-38,725
| -3% | -$16.4M |
|
267
Cboe Global Markets
CBOE
$30.4B
| $562M | 0.07% |
4,963,050
-1,260,183
| -20% | -$141M |
|
268
PG&E
PCG
$38.3B
| $561M | 0.07% |
56,215,681
-24,838,095
| -31% | -$292M |
|
269
Ionis Pharmaceuticals
IONS
$9.39B
| $557M | 0.07% |
15,056,046
+705,586
| +5% | +$26.6M |
|
270
Cintas
CTAS
$81.4B
| $556M | 0.07% |
5,953,112
-686,616
| -10% | -$66.9M |
|
271
Trip.com Group
TCOM
$28.7B
| $546M | 0.07% |
19,888,322
-10,334,543
| -34% | -$231M |
|
|
SEM
272
DELISTED
Select Medical
SEM
| $544M | 0.07% |
42,709,949
+736,123
| +2% | +$9.45M |
|
273
Baidu
BIDU
$35.6B
| $543M | 0.07% |
3,653,778
-2,019,046
| -36% | -$267M |
|
274
Dollar Tree
DLTR
$24.7B
| $543M | 0.07% |
3,484,644
-1,827,140
| -34% | -$290M |
|
275
Equity Lifestyle Properties
ELS
$12.4B
| $541M | 0.07% |
7,680,048
+586,740
| +8% | +$43.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.